Latest News | Lupin Gets EIR from USFDA for Mandideep Plant

New Delhi, Oct 31 (PTI) Drug firm Lupin on Tuesday said it has received Establishment Inspection Report (EIR) from the US health regulator for its Mandideep Unit-2 manufacturing facility in Madhya Pradesh.

Also Read | Chhattisgarh Rajyotsava 2023 Date, Origin & Significance: From History to Cultural Traditions, Everything To Know About Chhattisgarh Foundation Day.

The US Food and Drug Administration (USFDA) issues an EIR to a company when an inspection is satisfactorily closed.

The EIR was issued post the last inspection of the facility conducted from August 7 to August 11, 2023, Lupin said in a regulatory filing.

Also Read | Karnataka Rajyotsava 2023 Date, Traditions, History & Significance: Everything You Need To Know About Celebrating Karnataka Day.

Shares of the drug firm ended 1.04 per cent down at Rs 1,128.40 apiece on the BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)